Diets could prevent many diseases

Lipids

Volumn 38, Issue 4, 2003, Pages 317-321

  Lands, William E M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER SOFTWARE; DISEASES; FATTY ACIDS; METABOLISM; NUTRITION; TISSUE;

DIETITIANS;

LIPIDS;

ESSENTIAL FATTY ACID; ICOSANOID;

COMPUTER PROGRAM; CONFERENCE PAPER; COUNSELING; DIET; DIET COUNSELING; DIET THERAPY; DIET TISSUE DISEASE RELATION; DIETITIAN; FATTY ACID METABOLISM; MEDICAL EDUCATION; NUTRITION; PREVENTIVE MEDICINE; QUANTITATIVE ANALYSIS;

CLINICAL TRIALS; CORONARY DISEASE; DIET; DIETARY FATS; EICOSANOIDS; FATTY ACIDS, ESSENTIAL; FOOD PREFERENCES; HUMANS; RISK FACTORS;

EID: 0037971513     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-003-1066-0     Document Type: Conference Paper

References (17)

1. Lands, W.E.M. (1979) The Biosynthesis and Metabolism of Prostaglandins, Annu. Rev. Physiol. 41, 633-652.
2. Kulmacz, R.J., Pendleton, R.B., and Lands, W.E.M. (1994) Interaction Between Peroxidase and Cyclooxygenase Activities in Prostaglandin-Endoperoxide Synthase, J. Biol. Chem. 269, 5527-5536.
3. Malkowski, M.G., Thuresson, E.D., Lakkides, K.M., Rieke, C.J., Micielli, R., Smith, W.L., and Garavito, R.M. (2001) Structure of Eicosapentaenoic and Linoleic Acids in the Cyclooxygenase Site of Prostaglandin Endoperoxide H Synthase-1, J. Biol. Chem. 276, 37547-37555.
4. Needleman, P., Raz, A., Minkes, M.S., Ferrendelli, J.A., and Sprecher, H. (1979) Triene Prostaglandins: Prostacyclin and Thromboxane Biosynthesis and Unique Biological Properties, Proc. Natl. Acad. Sci. USA 76, 944-948.
5. Lands, W.E.M., and Samuelsson, B. (1968) Phospholipid Precursors of Prostaglandin, Biochim. Biophys. Acta 164, 426-429.
6. Mohrhauer, H., and Holman, R.T. (1963) Effect of Linolenic Acid upon the Metabolism of Linoleic Acid, J. Nutr. 81, 67-74.
7. Mohrhauer, H., and Holman, R.T. (1963) The Effect of Dose Level of Essential Fatty Acids upon Fatty Acid Composition of the Rat Liver, J. Lipid Res. 4, 151-159.
8. Harris, W.S., Ginsberg, H., Arunakul, N., Shachter, N.S., Windsor, S.L., Adams, M., Berglund, L., and Osmundsen, K. (1997) Safety and Efficacy of Omacor in Severe Hypertriglyceridemia, J. Cardiovasc. Risk 4, 385-391.
9. Kobayashi, M., Sasaki, S., Kawabata, T., Hasegawa, K., Akabane, M., and Tsugane, S. (2001) Single Measurement of Serum Phospholipid Fatty Acid as a Biomarker of Specific Fatty Acid Intake in Middle-Aged Japanese Men, Eur. J. Clin. Nutr. 55, 643-650.
10. Lands, W.E.M., Hamazaki, T., Yamazaki, K., Okuyama, H., Sakai, K., Goto, Y., and Hubbard, V.S. (1990) Changing Dietary Patterns, Am. J. Clin. Nutr. 51, 991-993.
11. Lands, W.E.M. (1991) Biosynthesis of Prostaglandins, Annu. Rev. Nutr. 11, 41-60.
12. Lands, W.E.M., Libelt, B., Morris, A., Kramer, N.C., Prewitt, T.E., Bowen, P., Schmeisser, D., Davidson, M.H., and Burns, J.H. (1992) Maintenance of Lower Proportions of n-6 Eicosanoid Precursors in Phospholipids of Human Plasma in Response to Added Dietary n-3 Fatty Acids, Biochim. Biophys. Acta 1180, 147-162.
13. Dolecek, T.A., and Granditis, G. (1991) Dietary Polyunsaturated Fatty Acids and Mortality in the Multiple Risk Factor Intervention Trial (MRFIT), World Rev. Nutr. Diet. 66, 205-216.
14. Dewailly, E., Blanchet, C., Lemieux, S., Sauve, L., Gingras, S., Ayotte, P., and Holub, B.J. (2002) n-3 Fatty Acids and Cardiovascular Disease Risk Factors Among the Inuit of Nunavik, Am. J. Clin. Nutr. 76, 85-92.
15. Dewailly, E., Blanchet, C., Gingras, S., Lemieux, S., and Holub, B.J. (2002) Cardiovascular Disease Risk Factors and n-3 Fatty Acid Status in the Adult Population of James Bay Cree, Am. J. Clin. Nutr. 76, 85-92.
16. Dewailly, E.E., Blanchet, C., Gingras, S., Lemieux, S., Sauve, L., Bergeron, J., and Holub, B.J. (2001) Relations Between n-3 Fatty Acid Status and Cardiovascular Disease Risk Factors Among Quebecers, Am. J. Clin. Nutr. 74, 603-611.
17. Simon, J.A., Hodgkins, M.L., Browner, W.S., Neuhaus, J.M., Bernert, J.T., and Hulley, S.B. (1995) Serum Fatty Acids and the Risk of Coronary Heart Disease, Am. J. Epidemiol. 142, 469-476.